“The compound SR-17018 is the primary biased agonist on the mu opioid receptor that does not result in tolerance with chronic use,” suggests Stahl, a senior team scientist in the Bohn lab. “This is a attractive aspect for probable use from the context of Continual, serious pain.” Click on https://9royalstreet.com/product/sr-17018-vendor/